Sign inJoin waitlistJoin the waitlist

SS

Sarah Sammons

Adjunct Assistant Professor in the Department of Medicine · Duke Department of Medicine

Credentials: · ·

History

Duke Department of Medicine
Present
Duke Cancer Institute
Present

Jefferson Medical College of Thomas Jefferson University
2012

Research

Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers
Cancer Biology & Therapy · 2010 · 115 citations
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial
Journal of Clinical Oncology · 2025 · 91 citations
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors
Journal for ImmunoTherapy of Cancer · 2019 · 81 citations

Nancy Lin
25 papers
Sara Tolaney
24 papers
Carey Anders
18 papers
PT
Paolo Tarantino
11 papers
KB
Kimberly Blackwell
6 papers
Laura Alder
6 papers
Ayal Aizer
5 papers
EH
Erika Hamilton
5 papers
Ilana Schlam
5 papers · 3 as a fellow
Alyssa Pereslete
4 papers · 3 as a resident
Antonio Giordano
4 papers
Eric Winer
4 papers

Clinical trials

Neoadjuvant Immunotherapy in Brain Metastases
Principal investigator · Terminated · Phase 2
Sarah Sammons, MD
2020–2021
Impact of Endocrine Therapy and Abemaciclib on Host and Tumor Immune Cell Repertoire/Function in Advanced ER+/HER2- Breast Cancer
Principal investigator · Completed · Phase 2
Duke University
2020–2025
Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA)
Principal investigator · Completed · Phase 2
Duke University
2018–2022